Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3960 participants
OBSERVATIONAL
2013-03-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrative Therapy of Chronic Diseases
NCT04927403
Homeopathic Drug Proving Trial
NCT01061229
Effectiveness of Homeopathic Treatment in Female Infertility
NCT02175498
Effect of Homeopathy, Acupuncture or Anthroposophic Medicine in Women's Quality of Life
NCT02504515
Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis
NCT01242592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In an observational study we plan to compare patients participating in the integrated care project with matched insured persons from the Techniker Krankenkasse that do not participate in this program.
Matching will be based on gender, age and diagnosis. Regarding the diagnosis, we plan to include adolescents with: asthma, allergic rhinitis and atopic eczema; and adults with asthma, allergic rhinitis and atopic migraine, headache and depression.
To measure effectiveness, patients have to complete diagnosis-specific questionnaires at baseline and 3, 6 and 12 months. The primary outcome for each diagnosis is measured with diagnosis-specific questionnaire at 6 months. Secondary outcomes include quality of life (SF-12) at 3, 6 and 12 months as well as the diagnosis-specific questionnaires at 3 and 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated care
Insured people in the Techniker Krankenkasse that are registered in the integrated care project.
No interventions assigned to this group
Control group
Insured people in the Techniker Krankenkasse that are not registered in the integrated care project.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Insured for at least 1 year at the Techniker Krankenkasse
* Having access to the internet and e-mails at least once a week
* Adults with any of the following diagnoses: asthma, allergic rhinitis, atopic eczema, migraine, tension headache, depression
* Adolescents with any of the following diagnoses: asthma, allergic rhinitis, atopic eczema
* informed written consent
Exclusion Criteria
* Participation in an intervention study
* Cancer diagnosis
* current usage of a complementary therapy (control group only)
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia M. Witt
Prof. Dr. med, MBA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia M Witt, MD, MBA
Role: PRINCIPAL_INVESTIGATOR
Charite Universitätsmedizin Berlin
Thomas Reinhold, PhD
Role: PRINCIPAL_INVESTIGATOR
Charite-Universitätsmedizin Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Social Medicine, Epidemiology and Health Economics Charité Universitätsmedizin Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kass B, Icke K, Witt CM, Reinhold T. Effectiveness and cost-effectiveness of treatment with additional enrollment to a homeopathic integrated care contract in Germany. BMC Health Serv Res. 2020 Sep 15;20(1):872. doi: 10.1186/s12913-020-05706-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-Witt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.